Parkinson's disease
Education on emerging research questions linking Parkinson's disease and Alpha-1 Antitrypsin, clearly labeled as hypothesis.
Research status: Investigational / hypothesis
Research hypothesis, not medical advice
The connections described on this page come from Mark Egly's patent filing and ongoing research. They are not established medical facts. Always work with your physician for diagnosis and treatment.
Research hypothesis. Possible connections between Parkinson's disease and Alpha-1 Antitrypsin Deficiency (AATD) on this page reflect Mark Egly's research framing. They are not established medical fact and are not medical advice. Always work with your neurology team.
What is Parkinson's disease?
Parkinson's disease is a progressive neurological condition that affects movement, often with tremor, stiffness, and slowed motion. Diagnosis and treatment belong with neurology specialists and established clinical guidelines.
Why this page exists
Searches for Parkinson's disease are enormous. Very little public content connects Parkinson's topics to AATD. The Mark Egly Foundation publishes hypothesis labeled education so patients and clinicians can explore research questions without confusing them for proven care.
Established AATD education first
If you are new to Alpha-1, start here:
Research framing
Mark's patent explores inflammation, neutrophil activity, and AAT levels across many organ systems, including neurological disease names in our catalog. Inclusion signals research interest, not proven cause and effect for Parkinson's disease.
Related neurological pages
What you can do
- Continue neurology guided care for Parkinson's disease.
- Ask about AAT testing only when lung or liver findings or family history raise the question.
- Read the patent overview for research context.
- Support research if you want more independent study in this space.
Sources and references
References checked July 26, 2026
- Alpha-1 antitrypsin deficiency (MedlinePlus Genetics (NIH))Research status: Established clinical knowledge
- American Thoracic Society / European Respiratory Society statements on lung disease (locate current AATD guidance) (American Thoracic Society)Research status: Established clinical knowledgeUse the current ATS/ERS AATD statements applicable to your practice.
- Method of Preventing and/or Treating a Plurality of Diseases (Mark Egly patent disclosure summary) (Mark Egly Foundation patent overview)Research status: Investigational / hypothesisPrimary source for Mark Egly research hypotheses. Not peer-reviewed clinical evidence. Confirm USPTO application number with counsel before citing externally.
Educational content only. Not a diagnosis or treatment plan. Work with your clinician for personal medical decisions.